Hospital Universitario 12 De Octubre — Madrid

Public research footprint of Hospital Universitario 12 De Octubre, compiled from the ClinicalTrials.gov public registry.

1,585

Registered studies

643

Active

339

Recruiting now

660

Completed

193

Stopped or withdrawn

Most-studied conditions

Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Metastatic Colorectal Cancer · Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Neoplasm Metastasis

Recently updated registry entries

NCT07218029 — A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension… (Recruiting)
NCT07252232 — Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal… (Recruiting)
NCT07738575 — Same-Day Versus Standard Hospital Discharge After TAVI (HOME-TAVI) (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hospital Universitario 12 De Octubre?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.